The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2005

Filed:

Mar. 06, 2002
Applicants:

Joseph J. Florio, La Canada, CA (US);

Gene A. Bornzin, Simi Valley, CA (US);

Peter Boileau, Valencia, CA (US);

Eric Falkenberg, Simi Valley, CA (US);

Janice Barstad, Maple Grove, MN (US);

Inventors:

Joseph J. Florio, La Canada, CA (US);

Gene A. Bornzin, Simi Valley, CA (US);

Peter Boileau, Valencia, CA (US);

Eric Falkenberg, Simi Valley, CA (US);

Janice Barstad, Maple Grove, MN (US);

Assignee:

Pacesetter, Inc., Sylmar, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N001/18 ;
U.S. Cl.
CPC ...
Abstract

An implantable cardiac stimulation device is described wherein a controller of the cardiac stimulation device controls selected functions of the device based on whether the patient is at rest and further based on whether the patient is prone to vagally-mediated arrhythmias. Functions of the device that may be controlled include, for example, a pacing base rate, an AV/PV delay, and a refractory period as well as overdrive pacing parameters and diagnostic data gathering parameters. In one example, if the patient is not prone to vagally-mediated arrhythmias, the base rate is lowered while the patient is at rest. Also, overdrive pacing parameters are set to be less aggressive. As such, the operation of the cardiac stimulation device is controlled to make it easier for the patient to rest while also reducing power consumption. However, if the patient is prone to vagally-mediated arrhythmias, the base rate is not lowered while the patient is at rest. Overdrive pacing parameters are instead set to be more aggressive, rather than less aggressive. In this manner, the cardiac stimulation device attempts to compensate for any increased risk of arrhythmia that may occur while the patient, who is prone to vagally-mediated arrhythmias, is at rest. Numerous other parameters may be adjusted dependent upon whether the patient is at rest or dependent upon whether the patient is prone to vagally-mediated arrhythmias.


Find Patent Forward Citations

Loading…